Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

ClinicalTrials.gov ID: NCT03256240

Public ClinicalTrials.gov record NCT03256240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 10, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prospective Randomized Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis in the Prevention of Post-operative Recurrence of Crohn's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective trial. Patients with Crohn's ileitis or Crohn's ileocolitis requiring resection will be randomized to undergo either the Kono-S anastomosis or the side-to-side functional end anastomosis.

Study identification

NCT ID: NCT03256240
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Weill Medical College of Cornell University; Other
Enrollment: 600 participants

Conditions and interventions

Conditions

Crohn's Disease

Interventions

side-to-side functional end anastomosis Other
Kono-S analstomosis Other

Other

Eligibility (public fields only)

Age range: 18 Years to 90 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Mar 12, 2014 (Actual)
Primary completion: Jul 31, 2030 (Estimated)
Completion: Dec 31, 2036 (Estimated)
Last update posted: May 14, 2026

2014 – 2036

United States locations

U.S. sites: 6
U.S. states: 5
U.S. cities: 6

Facility	City	State	ZIP	Site status
Massachusetts General Hospital	Boston	Massachusetts	02114	Terminated
Weill Cornell Medical College	New York	New York	10065	Recruiting
University of Oklahoma	Oklahoma City	Oklahoma	73112	Terminated
Baylor Scott & White Research Institute	Dallas	Texas	75204	Terminated
Baylor College of Medicine	Houston	Texas	77030	Terminated
University of Washington Medical Center	Seattle	Washington	98195	Terminated

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT03256240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted May 14, 2026 · Synced Nov 10, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03256240 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →